Enlivex Therapeutics
Total Raised
$17.26MInvestors Count
5Deal Terms
1Funding, Valuation & Revenue
6 Fundings
Enlivex Therapeutics has raised $17.26M over 6 rounds.
Enlivex Therapeutics's latest funding round was a PIPE for $212M on November 24, 2025.
Enlivex Therapeutics's valuation in September 2017 was $50M.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
11/24/2025 | PIPE | $212M | Undisclosed Investors | 3 | ||
3/26/2019 | Reverse Merger | |||||
9/19/2017 | Series B | $50M | ||||
5/19/2014 | Convertible Note - II | |||||
1/22/2013 | Convertible Note |
Date | 11/24/2025 | 3/26/2019 | 9/19/2017 | 5/19/2014 | 1/22/2013 |
|---|---|---|---|---|---|
Round | PIPE | Reverse Merger | Series B | Convertible Note - II | Convertible Note |
Amount | $212M | ||||
Investors | Undisclosed Investors | ||||
Valuation | $50M | ||||
Revenue | |||||
Sources | 3 |
Enlivex Therapeutics Deal Terms
1 Deal Term
Enlivex Therapeutics's deal structure is available for 1 funding round, including their Series B from September 19, 2017.
Round | Series B |
|---|---|
Funding Date | |
Pre-Money Valuation | |
Post-Money Valuation | |
Amount Raised | |
Shares Authorized | |
Issuance Price | |
Dividend Rate | |
Liquidation Preferences | |
Liquidation Price | |
Participation | |
Conversion Price | |
Anti Dilution | |
General Voting | |
Board Voting | |
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series B |
Enlivex Therapeutics Investors
5 Investors
Enlivex Therapeutics has 5 investors. BioBlast Pharma invested in Enlivex Therapeutics's Reverse Merger funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
3/26/2019 | 3/26/2019 | 1 Reverse Merger | Corporation | Israel | ||
Corporation | Israel | |||||
Venture Capital | South Korea | |||||
Angel Investor (Individual) | ||||||
Venture Capital | Israel |
First funding | 3/26/2019 | ||||
|---|---|---|---|---|---|
Last Funding | 3/26/2019 | ||||
Investor | |||||
Rounds | 1 Reverse Merger | ||||
Board Seats | |||||
Type | Corporation | Corporation | Venture Capital | Angel Investor (Individual) | Venture Capital |
Location | Israel | Israel | South Korea | Israel |
Loading...